340B And Innovation: Study Says Hospitals Keeping Rx Payments That Could Otherwise Fuel Drug R&D
Executive Summary
Funded in part by Arnold Ventures, the NEJM study offers more data supporting the Rx industry’s call for 340B reform, and another perspective on how the savings could be used to benefit patients.